BusinessMANF Therapeutics Announces Issuance of Patent in Hong Kong Covering Use of MANF for Treatment of Diabetes and Wolfram'sBy Nasdaq OMXMay 3, 2018, 1:15 PM UTC
BusinessAmarantus Subsidiary MANF Therapeutics Announces Positive Independent Peer-Reviewed Pre-Clinical Data for MANF in Parkinson’s DiseaseBy Nasdaq OMXJan 29, 2018, 2:02 PM UTC
BusinessAmarantus Subsidiary MANF Therapeutics Announces Issuance of Japanese Patent Covering Therapeutic Use of MANF in Treatment of Parkinson's DiseaseBy Nasdaq OMXDec 20, 2017, 2:02 PM UTC
BusinessAmarantus Subsidiary MANF Therapeutics Receives Notice of Allowance from U.S. Patent & Trademark Office Covering MANF Treatment of DiabetesBy Nasdaq OMXDec 11, 2017, 1:02 PM UTC
